Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Elekta AB's Extend System Receives Japanese Approval


Tuesday, 2 Apr 2013 11:00am EDT 

Elekta AB announced that its Japanese office, Elekta K.K., announced on April 2, 2013 that Elekta's Extend system for multi-session stereotactic radiosurgery has been approved by the Japanese Health Authority. Extend makes it possible to treat indications that were previously untreatable with Gamma Knife surgery. The ability to treat a broader range of targets and more challenging cases allows even more patients to benefit from Leksell Gamma Knife Perfexion equipped with Extend. 

Company Quote

75.6
-1.1 -1.43%
7:59am EDT